Vericel Corporation (VCEL)

$38.34 +0.47 (1.24%)
Market Cap 1.96B
Revenue (ttm) 276.26M
Net Income (ttm) 16.52M
EPS (ttm) N/A
PE Ratio 80.57
Forward PE 69.81
Profit Margin 5.98%
Debt to Equity Ratio 0.00
Volume 503,500
Avg Vol 484,136
Day's Range N/A - N/A
Shares Out 51.21M
Stochastic %K 24%
Beta 1.04
Analysts Strong Sell
Price Target $60.57

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 588 5555
Fax: 617 588 5554
Address:
25 Blue Sky Drive, Burlington, United States
Pro_From_Dover
Pro_From_Dover Sep. 10 at 7:57 PM
$VCEL this management team is either liars, stupid, clueless, incompetent, stoned or all of the above. 49ish hit at earnings and its drop onward near 11$? Time to oust these idjits.
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 5:27 PM
$VCEL 37’s, here we come… again. This company blows chunks.
0 · Reply
Twister8
Twister8 Sep. 10 at 3:20 PM
$VCEL mid 30's get tasty
0 · Reply
Bulski69
Bulski69 Sep. 9 at 3:02 AM
$VCEL absolutely pitiful. They don’t seem to care about shareholder value these days 🤷🏻‍♂️
1 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 8 at 3:15 PM
$VCEL screwed over once more
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 4 at 6:09 PM
$VCEL piece.of.shit
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 1 at 8:27 PM
$VCEL lame is as lame does…
0 · Reply
Bulski69
Bulski69 Aug. 31 at 10:36 PM
$VCEL pathetic
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 31 at 3:39 PM
$VCEL holy crap… wtf is going on here to be down almost 10$ since earnings and news?
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 31 at 1:02 PM
$VCEL 30’s on the way? SMH. 🤦‍♂️
1 · Reply
Latest News on VCEL
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

Sep 8, 2026, 8:30 AM EDT - 5 days ago

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

Vericel price target raised to $58 from $55 at TD Cowen

2026-07-31T12:55:57.000Z - 6 weeks ago

Vericel price target raised to $58 from $55 at TD Cowen

Vericel Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Vericel Earnings Call Transcript: Q2 2026

Vericel Slides: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Vericel Slides: Q2 2026

Vericel Earnings release: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Vericel Earnings release: Q2 2026

Vericel Quarterly report: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Vericel Quarterly report: Q2 2026

Vericel reports Q2 EPS 4c, consensus (3c)

2026-07-30T12:05:29.000Z - 6 weeks ago

Vericel reports Q2 EPS 4c, consensus (3c)

Vericel raises FY26 revenue view to $330M-$340M from $326M-$336M

2026-07-30T12:05:18.000Z - 6 weeks ago

Vericel raises FY26 revenue view to $330M-$340M from $326M-$336M

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Jul 30, 2026, 7:55 AM EDT - 6 weeks ago

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Vericel price target raised to $54 from $42 at Truist

2026-07-16T14:10:17.000Z - 1 month ago

Vericel price target raised to $54 from $42 at Truist

Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026

Jul 16, 2026, 8:30 AM EDT - 1 month ago

Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026

Vericel Transcript: Truist Securities MedTech Conference 2026

Jun 16, 2026, 11:20 AM EDT - 2 months ago

Vericel Transcript: Truist Securities MedTech Conference 2026

Vericel Slides: FY 2026

Jun 16, 2026, 11:20 AM EDT - 2 months ago

Vericel Slides: FY 2026

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Jun 9, 2026, 8:30 AM EDT - 3 months ago

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Vericel price target raised to $70 from $64 at H.C. Wainwright

2026-05-08T10:29:58.000Z - 4 months ago

Vericel price target raised to $70 from $64 at H.C. Wainwright

Vericel reports Q1 EPS (12c), consensus (16c)

2026-05-07T19:06:49.000Z - 4 months ago

Vericel reports Q1 EPS (12c), consensus (16c)

Vericel raises FY26 revenue guidance to $326M-$336M from $316M-$326M

2026-05-07T19:04:46.000Z - 4 months ago

Vericel raises FY26 revenue guidance to $326M-$336M from $316M-$326M

Vericel Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Vericel Earnings Call Transcript: Q1 2026

Vericel Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Vericel Earnings release: Q1 2026

Vericel Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Vericel Slides: Q1 2026

Vericel Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Vericel Quarterly report: Q1 2026

Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

May 7, 2026, 7:45 AM EDT - 4 months ago

Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

Vericel Transcript: AGM 2026

Apr 29, 2026, 9:00 AM EDT - 4 months ago

Vericel Transcript: AGM 2026

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

Vericel price target lowered to $42 from $48 at Truist

2026-04-15T12:49:05.000Z - 5 months ago

Vericel price target lowered to $42 from $48 at Truist

MediWound says Vericel awarded ten-year contract valued at up to $197M

2026-04-02T19:37:47.000Z - 5 months ago

MediWound says Vericel awarded ten-year contract valued at up to $197M

MDWD

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

Apr 2, 2026, 2:40 PM EDT - 5 months ago

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

Vericel awarded Health and Human Services contract valued at $196.87M

2026-04-02T17:30:15.000Z - 5 months ago

Vericel awarded Health and Human Services contract valued at $196.87M

Vericel Proxy statement: Proxy filing

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Vericel Proxy statement: Proxy filing

Vericel Proxy statement: Proxy filing

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Vericel Proxy statement: Proxy filing

Vericel Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 8:40 AM EDT - 6 months ago

Vericel Transcript: Leerink Global Healthcare Conference 2026

Vericel Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 9:50 AM EST - 6 months ago

Vericel Transcript: TD Cowen 46th Annual Health Care Conference

Vericel announces U.S. FDA approval of new manufacturing facility

2026-03-04T13:05:09.000Z - 6 months ago

Vericel announces U.S. FDA approval of new manufacturing facility

Vericel price target raised to $64 from $60 at H.C. Wainwright

2026-02-27T16:15:34.000Z - 6 months ago

Vericel price target raised to $64 from $60 at H.C. Wainwright

Vericel Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Vericel Earnings Call Transcript: Q4 2025

Vericel Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Vericel Annual report: Q4 2025

Vericel Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Vericel Annual report: Q4 2025

Vericel Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Vericel Earnings release: Q4 2025

Vericel Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Vericel Slides: Q4 2025

Vericel reports Q4 EPS 45c, consensus 38c

2026-02-26T13:23:55.000Z - 6 months ago

Vericel reports Q4 EPS 45c, consensus 38c

Vericel sees FY26 revenue $316M-$326M, consensus $325.31M

2026-02-26T13:23:03.000Z - 6 months ago

Vericel sees FY26 revenue $316M-$326M, consensus $325.31M

Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 26, 2026, 7:55 AM EST - 6 months ago

Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

These under-the-radar stocks combine fast growth with big upside potential

Jan 15, 2026, 10:31 AM EST - 8 months ago

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

Vericel Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 2:15 PM EST - 8 months ago

Vericel Transcript: 44th Annual J.P. Morgan Healthcare Conference

Vericel Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 2:15 PM EST - 8 months ago

Vericel Slides: 44th Annual J.P. Morgan Healthcare Conference

Vericel reports preliminary FY25 revenue $276M, consensus $274.11M

2026-01-13T14:06:14.000Z - 8 months ago

Vericel reports preliminary FY25 revenue $276M, consensus $274.11M

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Jan 13, 2026, 9:00 AM EST - 8 months ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Jan 6, 2026, 8:30 AM EST - 8 months ago

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Vericel price target lowered to $45 from $50 at Truist

2025-12-18T14:21:00.000Z - 8 months ago

Vericel price target lowered to $45 from $50 at Truist

Vericel Transcript: Stephens Annual Investment Conference

Nov 20, 2025, 11:00 AM EST - 9 months ago

Vericel Transcript: Stephens Annual Investment Conference

Vericel Slides: Corporate presentation

Nov 19, 2025, 7:00 AM EST - 9 months ago

Vericel Slides: Corporate presentation

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Vericel price target raised to $50 from $41 at Truist

2025-11-07T20:05:21.000Z - 10 months ago

Vericel price target raised to $50 from $41 at Truist

Vericel Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Vericel Earnings Call Transcript: Q3 2025

Vericel Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Vericel Quarterly report: Q3 2025

Vericel Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Vericel Earnings release: Q3 2025

Vericel Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Vericel Slides: Q3 2025

Vericel reports Q3 EPS 10c, consensus (1c)

2025-11-06T13:01:38.000Z - 10 months ago

Vericel reports Q3 EPS 10c, consensus (1c)

Vericel sees FY25 revenue $272M-$276M, consensus $275.21M

2025-11-06T13:01:25.000Z - 10 months ago

Vericel sees FY25 revenue $272M-$276M, consensus $275.21M

Vericel Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:55 AM EST - 10 months ago

Vericel Reports Third Quarter 2025 Financial Results

Vericel price target lowered to $41 from $46 at Truist

2025-10-15T12:50:24.000Z - 11 months ago

Vericel price target lowered to $41 from $46 at Truist

Vericel Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 3:45 PM EDT - 1 year ago

Vericel Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Aug 28, 2025, 8:30 AM EDT - 1 year ago

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Vericel Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Vericel Earnings Call Transcript: Q2 2025

Vericel Quarterly report: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Vericel Quarterly report: Q2 2025

Vericel Earnings release: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Vericel Earnings release: Q2 2025

Vericel Slides: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Vericel Slides: Q2 2025

Vericel Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 8:08 AM EDT - 1 year ago

Vericel Reports Second Quarter 2025 Financial Results

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Jul 17, 2025, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Vericel Transcript: 2025 Truist Securities MedTech Conference

Jun 17, 2025, 9:20 AM EDT - 1 year ago

Vericel Transcript: 2025 Truist Securities MedTech Conference

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Jun 10, 2025, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Vericel Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 12:20 PM EDT - 1 year ago

Vericel Transcript: BofA Securities 2025 Healthcare Conference

Vericel Slides: Company Presentation

May 13, 2025, 7:00 AM EDT - 1 year ago

Vericel Slides: Company Presentation

Vericel Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Vericel Earnings Call Transcript: Q1 2025

Vericel Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Vericel Quarterly report: Q1 2025

Vericel Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Vericel Earnings release: Q1 2025

Vericel Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Vericel Slides: Q1 2025

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 8, 2025, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Vericel Proxy statement: Proxy Filing

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Vericel Proxy statement: Proxy Filing

Vericel Proxy statement: Proxy Filing

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Vericel Proxy statement: Proxy Filing

Vericel to Present at Multiple Upcoming Investor Conferences

Mar 4, 2025, 8:30 AM EST - 1 year ago

Vericel to Present at Multiple Upcoming Investor Conferences

Vericel Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Vericel Earnings Call Transcript: Q4 2024

Vericel Annual report: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Vericel Annual report: Q4 2024

Vericel Earnings release: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Vericel Earnings release: Q4 2024

Vericel Slides: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Vericel Slides: Q4 2024

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 7:54 AM EST - 1 year ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Vericel Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 10:30 AM EST - 1 year ago

Vericel Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Vericel Slides: FY 2025

Jan 15, 2025, 10:30 AM EST - 1 year ago

Vericel Slides: FY 2025

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Jan 14, 2025, 4:05 PM EST - 1 year ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Vericel Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Vericel Earnings Call Transcript: Q3 2024

Vericel Quarterly report: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Vericel Quarterly report: Q3 2024

Vericel Earnings release: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Vericel Earnings release: Q3 2024

Vericel Slides: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Vericel Slides: Q3 2024

Vericel Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2024 Financial Results

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Vericel Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 6, 2024, 1:05 PM EDT - 2 years ago

Vericel Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 29, 2024, 9:17 AM EDT - 2 years ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 26, 2024, 7:45 AM EDT - 2 years ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:05 PM EDT - 2 years ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Vericel Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 14, 2024, 3:00 PM EDT - 2 years ago

Vericel Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 7, 2024, 8:30 AM EDT - 2 years ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Vericel Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Vericel Earnings Call Transcript: Q2 2024

Vericel Quarterly report: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Vericel Quarterly report: Q2 2024

Vericel Earnings release: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Vericel Earnings release: Q2 2024

Vericel Slides: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Vericel Slides: Q2 2024

Vericel Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 7:55 AM EDT - 2 years ago

Vericel Reports Second Quarter 2024 Financial Results

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 22, 2024, 8:30 AM EDT - 2 years ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 2 years ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Vericel Transcript: 2024 Truist Securities MedTech Conference

Jun 18, 2024, 2:30 PM EDT - 2 years ago

Vericel Transcript: 2024 Truist Securities MedTech Conference

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Jun 11, 2024, 8:30 AM EDT - 2 years ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Vericel Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

May 29, 2024, 9:40 AM EDT - 2 years ago

Vericel Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 22, 2024, 8:30 AM EDT - 2 years ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

Vericel Earnings Call Transcript: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

Vericel Earnings Call Transcript: Q1 2024

Vericel Quarterly report: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

Vericel Quarterly report: Q1 2024

Vericel Earnings release: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

Vericel Earnings release: Q1 2024

Vericel Slides: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

Vericel Slides: Q1 2024

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

May 8, 2024, 7:55 AM EDT - 2 years ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 8:30 AM EDT - 2 years ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Vericel Proxy statement: Proxy Filing

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Vericel Proxy statement: Proxy Filing

Vericel Proxy statement: Proxy Filing

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Vericel Proxy statement: Proxy Filing

Vericel Transcript: TD Cowen 44th Annual Health Care Conference 2024

Mar 5, 2024, 11:10 AM EST - 2 years ago

Vericel Transcript: TD Cowen 44th Annual Health Care Conference 2024

Vericel Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:30 AM EST - 2 years ago

Vericel Earnings Call Transcript: Q4 2023

Vericel Annual report: Q4 2023

Feb 29, 2024, 8:30 AM EST - 2 years ago

Vericel Annual report: Q4 2023

Vericel Earnings release: Q4 2023

Feb 29, 2024, 8:30 AM EST - 2 years ago

Vericel Earnings release: Q4 2023

Vericel Slides: Q4 2023

Feb 29, 2024, 8:30 AM EST - 2 years ago

Vericel Slides: Q4 2023

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 29, 2024, 7:55 AM EST - 2 years ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 27, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 15, 2024, 8:30 AM EST - 2 years ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Vericel Transcript: Canaccord Genuity 2024 Musculoskeletal Conference

Feb 12, 2024, 11:00 AM EST - 2 years ago

Vericel Transcript: Canaccord Genuity 2024 Musculoskeletal Conference

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 5, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Vericel Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 10, 2024, 10:30 AM EST - 2 years ago

Vericel Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Vericel Slides: FY 2024

Jan 10, 2024, 10:30 AM EST - 2 years ago

Vericel Slides: FY 2024

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 9, 2024, 7:55 AM EST - 2 years ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Jan 3, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Vericel Transcript: Stephens Annual Investment Conference | NASH 2023

Nov 15, 2023, 10:00 AM EST - 2 years ago

Vericel Transcript: Stephens Annual Investment Conference | NASH 2023

Vericel Earnings Call Transcript: Q3 2023

Nov 8, 2023, 8:30 AM EST - 2 years ago

Vericel Earnings Call Transcript: Q3 2023

Vericel Quarterly report: Q3 2023

Nov 8, 2023, 8:30 AM EST - 2 years ago

Vericel Quarterly report: Q3 2023

Vericel Earnings release: Q3 2023

Nov 8, 2023, 8:30 AM EST - 2 years ago

Vericel Earnings release: Q3 2023

Vericel Slides: Q3 2023

Nov 8, 2023, 8:30 AM EST - 2 years ago

Vericel Slides: Q3 2023

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 8, 2023, 7:55 AM EST - 2 years ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Present at the Stephens Annual Investment Conference

Nov 7, 2023, 8:30 AM EST - 2 years ago

Vericel to Present at the Stephens Annual Investment Conference

Vericel Slides: Corporate Presentation

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Vericel Slides: Corporate Presentation

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 28, 2023, 8:30 AM EDT - 2 years ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Sep 20, 2023, 4:30 PM EDT - 2 years ago

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Vericel Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Sep 12, 2023, 7:30 AM EDT - 3 years ago

Vericel Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Sep 6, 2023, 8:30 AM EDT - 3 years ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Vericel Earnings Call Transcript: Q2 2023

Aug 2, 2023, 8:30 AM EDT - 3 years ago

Vericel Earnings Call Transcript: Q2 2023

Vericel Quarterly report: Q2 2023

Aug 2, 2023, 8:30 AM EDT - 3 years ago

Vericel Quarterly report: Q2 2023

Vericel Earnings release: Q2 2023

Aug 2, 2023, 8:30 AM EDT - 3 years ago

Vericel Earnings release: Q2 2023

Vericel Slides: Q2 2023

Aug 2, 2023, 8:30 AM EDT - 3 years ago

Vericel Slides: Q2 2023

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Aug 2, 2023, 7:55 AM EDT - 3 years ago

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Pro_From_Dover
Pro_From_Dover Sep. 10 at 7:57 PM
$VCEL this management team is either liars, stupid, clueless, incompetent, stoned or all of the above. 49ish hit at earnings and its drop onward near 11$? Time to oust these idjits.
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 10 at 5:27 PM
$VCEL 37’s, here we come… again. This company blows chunks.
0 · Reply
Twister8
Twister8 Sep. 10 at 3:20 PM
$VCEL mid 30's get tasty
0 · Reply
Bulski69
Bulski69 Sep. 9 at 3:02 AM
$VCEL absolutely pitiful. They don’t seem to care about shareholder value these days 🤷🏻‍♂️
1 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 8 at 3:15 PM
$VCEL screwed over once more
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 4 at 6:09 PM
$VCEL piece.of.shit
0 · Reply
Pro_From_Dover
Pro_From_Dover Sep. 1 at 8:27 PM
$VCEL lame is as lame does…
0 · Reply
Bulski69
Bulski69 Aug. 31 at 10:36 PM
$VCEL pathetic
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 31 at 3:39 PM
$VCEL holy crap… wtf is going on here to be down almost 10$ since earnings and news?
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 31 at 1:02 PM
$VCEL 30’s on the way? SMH. 🤦‍♂️
1 · Reply
mktrdr59
mktrdr59 Aug. 30 at 5:22 PM
$VCEL forming bullish falling wedge at 50% retracement level of the Mar-Jul rally, at possible support from the early May high, and close to the abc measured move projection. Technical indicators very oversold.
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 28 at 8:03 PM
$VCEL down by roughly 20% from yearly high after 7/30 earnings and news. Duped again by their rhetoric. This isn’t like watching paint dry- it’s more like we just found out they completely replace the wall, reglazed it and fancied it up- yet now the paint is chipping, drywall crumbling and falling off, exposing the rotten wooden studs underneath.
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 28 at 1:38 PM
$VCEL looks like the spiral down ain’t complete. Nice work, douchebag management.
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 27 at 7:47 PM
$VCEL how incredibly pathetic
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 26 at 3:14 PM
$VCEL and away we (don’t) go….
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 24 at 1:39 PM
$VCEL one more time kicking myself for believing in this company, its growth and earnings claims and promises. Such agita watching this with mouth agape falling and falling to crap levels that we too recently experienced.
0 · Reply
Twister8
Twister8 Aug. 21 at 2:57 PM
$VCEL me like low 40's.
0 · Reply
jamco44
jamco44 Aug. 20 at 10:55 PM
$VCEL In the last pargraph of my previous post when i said"also around that same time" I was refering to 21
0 · Reply
jamco44
jamco44 Aug. 20 at 10:14 PM
$VCEL One person asked me in a reply what anew CEO would be able to do. Well how about if you cant help the share price dont hurt it. Back in 21 on one o fthe conference calls Our brilliant CEO was talking about a charge with compensation "due to the high share price"..What a stupid thing to say. I sent an email off right away to let him know that is something you do not say. I remember in 99 and Steve Ballmer was on CNBC and he said he thought the share price of Microsoft was to high. I was a shareholder. I called Microsoft and got through to his office. I got his email address. I sent him an email and ripped him a new one. I wasnt the only one. About a week later he was back on CNBC and he said "ill never mention the share price again. I learned my lesson" Also around that same time was when out great Mngmt. team dropped the ball on the Nexobrid application. We were at 67 and on our way to 80. They screwed it up and we went back to 20..Thats it for now...So does that answer your ques.
0 · Reply
jamco44
jamco44 Aug. 20 at 5:37 PM
$VCEL Yesterday the NBI Index had its biggest gain in one day in forever. And we were down. That is Nuts. I have a thought. I get them sometimes. Lol. The share buyback they announced on earnings day. I think they are doing some buying right now. But they want to make sure they get a good price so they are buying at these levels. They have a deal. With who or how I dont know. But they are buying the shares now and when they have bought enough than they will let it move Higher. The buyback sounded good but right now its a curse. I still say lest get new blood in Management. A young aggressive CEO who can take this and run with it. We should be at 60 right now.
4 · Reply
Bulski69
Bulski69 Aug. 20 at 1:30 PM
$VCEL wow….
0 · Reply
Pro_From_Dover
Pro_From_Dover Aug. 19 at 8:01 PM
$VCEL what a heaping, steamy, god awful smelling piece of 💩
0 · Reply